文献
J-GLOBAL ID:201702266488191927
整理番号:17A1719954
局所進行・切除不能または転移性尿路上皮癌(KEYNOTE 052)を用いたシスプラチン安易な患者における第一線pembrolizumab:多施設,単一群,第2相試験【Powered by NICT】
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
著者 (15件):
Balar Arjun V
(Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA)
,
Castellano Daniel
(Hospital Universitario 12 de Octubre (CiberOnc), Madrid, Spain)
,
O’Donnell Peter H
(University of Chicago Medical Center, Chicago, IL, USA)
,
Grivas Petros
(Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA)
,
Vuky Jacqueline
(Oregon Health & Science University, Portland, OR, USA)
,
Powles Thomas
(Barts Cancer Institute, Queen Mary University of London, London, UK)
,
Plimack Elizabeth R
(Fox Chase Cancer Center, Philadelphia, PA, USA)
,
Hahn Noah M
(Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA)
,
de Wit Ronald
(Erasmus MC Cancer Institute, Rotterdam, Netherlands)
,
Pang Lei
(Merck & Co, Kenilworth, NJ, USA)
,
Savage Mary J
(Merck & Co, Kenilworth, NJ, USA)
,
Perini Rodolfo F
(Merck & Co, Kenilworth, NJ, USA)
,
Keefe Stephen M
(Merck & Co, Kenilworth, NJ, USA)
,
Bajorin Dean
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
,
Bellmunt Joaquim
(Dana-Farber Cancer Institute, Boston, MA, USA)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
11
ページ:
1483-1492
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)